Stay informed. See MDA updates on COVID-19

Innovations in Care

We provide programs and services that transform the lives of people affected by neuromuscular disease.

Outside Organization Programs & Information

As part of our support to the neuromuscular disease community, MDA posts information provided by outside companies and organizations that are educational or research in nature.

The information, programs and resources listed below are not developed,  sponsored, funded or endorsed by MDA.  The companies and organizations posting below are responsible for all content and information provided. Any questions or queries, please email us at ResourceCenter@mdausa.org. Posting may not be for fundraising or commercial purposes.


Route 79, The Duchenne Scholarship Program

Sarepta Therapeutics has opened up applications for Route 79, The Duchenne Scholarship Program. Individuals living with Duchenne muscular dystrophy (DMD) who are pursuing post-secondary education (including trade, technical, and vocational school) are welcome to apply. The company will award 20 scholarships of up to $5,000 each. Applications will be open through April 15, 2020, and recipients will be notified prior to August 2020. Read the press release or visit the website to apply.


No Charge Genetic Testing for Patients Suspected of Having SMA

The SMA Identified Program offers no charge genetic testing for patients suspected of having or clinically diagnosed with SMA.  The link to the program is below:
https://www.invitae.com/en/sma-identified


Take on Thymidine Kinase 2 deficiency (TK2d)

Whether you're living with an MDS, have been diagnosed with TK2d or are a parent, caregiver, or healthcare professional (HCP) who wants to learn more about MDS and TK2d, visit www.tk2d.com for more information. We can all take on TK2d together.


Gene Therapy Patient Education

The American Society of Gene and Cell Therapy has a variety of educational resources available on their website. Visit https://www.asgct.org/education to learn more about the basics of gene therapy, the clinical trial process and the potential of gene therapy for specific diseases including SMA and MTM.